Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 |
| Katalog-Nr.GC31305 |
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 hat die potentielle Funktion bei StÖrungen des Zentralnervensystems, Atemwegserkrankungen, entzÜndlichen Erkrankungen und gastrointestinalen StÖrungen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 225526-17-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 has the potential function in central nervous system disorders, respiratory, inflammatory diseases and gastrointestinal disorders.
Piperidinylaminomethyl Trifluoromethyl Cyclic Ether Compound 1 has the potential function in numerous diseases, including central nervous system disorders such as depression, anxiety and schizophrenia, in respiratory and inflammatory diseases such as asthma and rheumatoid arthritis, in gastrointestinal disorders and diseases of the GI tract such as ulcerative colitis and Crohn's disease, and in the transmission of pain, including migraine[1].
[1]. Caron, Stephane, et al. Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds. EP1095939 A2.
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *